Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluated pembrolizumab in combination with carboplatin and paclitaxel for Stage III–IV ovarian, primary peritoneal, or fall…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer [Phase 2]
Phase 2 trial of HS-20089 for ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer [Phase 2]
Phase 2 neoadjuvant trial of RC48 plus carboplatin for HER2-expressing advanced ovarian cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor [Phase 2]
Phase 2 study evaluating the efficacy and safety of JPI-547 in platinum-resistant advanced or relapsed ovarian cancer patients previously tr…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Optimal Timing of BR55 CEUS of the Ovaries [Phase 2]
Phase 2 study evaluating the optimal timing of BR55 ultrasound contrast agent (CEUS) for imaging the ovaries in ovarian cancer; the trial wa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures [Phase 3]
Phase 3 pilot trial evaluating redosing liposomal bupivacaine for pain control in major gynecologic procedures has been terminated.
-
CLINICAL_TRIALS other · 2024-08-22Clinical Trial Update: Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer [Phase 3]
This is an update on a Phase 3 clinical trial evaluating cancer stem cell assay-directed chemotherapy for recurrent platinum-resistant ovari…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial of a cancer vaccine therapy combined with cyclophosphamide for patients with Stage II-III breast cancer or Stage II-IV ovarian…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating delayed initiation of olaparib maintenance in platinum-sensitive recurrent ovarian cancer was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors [Phase 1, Phase 2]
This update reports the termination of a Phase 1/2 trial of AMG 655 in combination with AMG 479 for advanced, refractory solid tumors, with …
-
CLINICAL_TRIALS withdrawal · 2024-08-20Clinical Trial Update: Intraperitoneal LSTA1 in CRS-HIPEC [Phase 1]
The document reports the withdrawal of a Phase 1 trial of intraperitoneal LSTA1 for peritoneal cancers. The conditions include colorectal ca…
-
CLINICAL_TRIALS other · 2024-08-20Clinical Trial Update: A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer [Phase 1, Phase 2]
This entry describes a Phase I/II clinical trial of UCB4594 for multiple advanced solid tumors, including head and neck squamous cell carcin…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women [NA]
This clinical trial evaluates the efficacy and safety of FRD001 as an ultrasound contrast agent for malignant ovarian masses and is currentl…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence
A clinical trial update describing exosome-based OCS scores aimed at predicting ovarian cancer recurrence; the study is currently NOT_YET_RE…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer [EARLY_Phase 1]
Early-phase trial evaluating pharmacogenomics-guided use of supportive care medications in patients with advanced cancers; the study has com…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update on the combination of Fluzoparib and Dalpiciclib for platinum-resistant recurrent ovarian cancer, with the s…
-
CLINICAL_TRIALS withdrawal · 2024-08-13Clinical Trial Update: Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating TNG348 alone and in combination with a PARP inhibitor for BRCA1/2-mutant or HRD-positive solid tumors has been …
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and early efficacy signals of KM1 in adults with recurrent or refractory ovarian…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK [Phase 1, Phase 2]
The ROCKIF trial is investigating re-sensitization of carboplatin-resistant ovarian cancer using a focal adhesion kinase (FAK) inhibitor, in…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients [Phase 1]
Phase 1 trial update on intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in patients with recurrent ovarian cancer, recurren…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating SHR-A1921 for injection in patients with platinum-resistant recurrent epithelial ovarian cancer is curre…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
A recruiting clinical trial studying 13C-glucose tracing of tumour and T cells in the ascites of patients with ovarian cancer to investigate…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling [NA]
A completed clinical trial evaluating genetic counseling augmented with an educational video or pamphlet versus traditional counseling metho…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients [Phase 2]
This entry describes a Phase 2 trial evaluating secondary cytoreduction followed by hyperthermic intraperitoneal chemotherapy for ovarian ca…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results
This clinical trial proposes a fast diffusion-weighted MRI protocol to surveil patients at high risk of ovarian cancer recurrence who are on…